Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

At the insurer's investor day, Humana struck a middle ground in defending the importance of the privatized Medicare program — ...

Humana leaders asserted at the company’s investor day Monday that there’s still money to be made on Medicare Advantage ...

As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay ...

This was the stock's fourth consecutive day of gains.

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks. Learn more about HUM stock here.

To achieve its goal, Humana told investors it's set several targets, including increasing preventative care visits by 20% this year.

BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I ...

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

AHIP CEO Mike Tuffin — who helps speak for Aetna, Cigna and the Blues — said the current One Big Beautiful Act package would ...

From UNC Health suing Aetna and Humana to Purdue Pharma reaching a settlement over its role in the opioid epidemic, here are 10 healthcare industry lawsuits, settlements and legal developments that ...